Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study

Correction to: A multicenter propensity score analysis of FOLFIRINOX vs gemcitabine plus nab-paclitaxel administered to patients with metastatic pancreatic cancer: results from the NAPOLEON study

In the original publication, Fig. 3 has been published incorrectly.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:International journal of clinical oncology 2021-05, Vol.26 (5), p.951-953
Hauptverfasser: Otsuka, Taiga, Shirakawa, Tsuyoshi, Shimokawa, Mototsugu, Koga, Futa, Kawaguchi, Yasunori, Ueda, Yujiro, Nakazawa, Junichi, Komori, Azusa, Otsu, Satoshi, Arima, Shiho, Fukahori, Masaru, Okabe, Yoshinobu, Makiyama, Akitaka, Taguchi, Hiroki, Honda, Takuya, Shibuki, Taro, Nio, Kenta, Ide, Yasushi, Mizuta, Toshihiko, Mitsugi, Kenji, Ureshino, Norio
Format: Artikel
Sprache:eng
Schlagworte:
Cancer Research
Correction
Medicine
Medicine & Public Health
Oncology
Surgical Oncology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:In the original publication, Fig. 3 has been published incorrectly.
ISSN:1341-9625
1437-7772
DOI:10.1007/s10147-021-01880-5